학술논문
Focused ultrasound therapy in movement disorders: management roadmap toward optimal pathway organization
Document Type
article
Author
Sara Rinaldo; Roberto Cilia; Valentina Leta; Mariarosaria Gammone; Nico Golfrè Andreasi; Fabiana Colucci; Arianna Braccia; Roberta Telese; Marco Fusar Poli; Vincenzo Levi; Luigi Michele Antonio Romito; Francesco Ghilemetti; Elena De Martin; Maria Luisa Fumagalli; Francesca Epifani; Sara Prioni; Paolo Amami; Sylvie Piacentini; Antonio Emanuele Elia; Grazia Devigili; Vittoria Nazzi; Elisa Francesca Maria Ciceri; Mario Stanziano; Marina Grisoli; Valentina Caldiera; Marisa Catotti; Francesco DiMeco; Giacomina Clara Moreschi; Roberto Eleopra
Source
Frontiers in Neurology, Vol 15 (2024)
Subject
Language
English
ISSN
1664-2295
Abstract
MRI-guided focused ultrasound (MRgFUS) lesioning is an innovative, safe and effective treatment which provides an innovative development in the field of minimally invasive stereotactic neurosurgery. Based on the application of focused ultrasound energy under full MR planning and thermal imaging control, unilateral lesioning of the thalamus, subthalamic nucleus, and globus pallidus is indicated for the treatment of movement disorders, including essential tremor, Parkinson’s disease, and dystonia. We started to apply this technique in February 2019 for the treatment of patients with movement disorders. The authors developed a diagnostic therapeutic care pathway, which is herewith proposed and applied as an explication of standard clinical practice in use. The project was the result of the application of different methods such as Health Technology Assessment (HTA), Strengths, Weaknesses, Opportunities and Threats analysis (SWOT) and Demin -Plan, Do, Check, Act (PDCA) cycle. The aim of this project was to standardize the MRgFUS diagnostic-therapeutic pathway (DTP), describe its application and the appropriateness of different phases (patient selection, intervention phase and follow-up). Here, we described in detail our experience in the DTP application from 2019 up to now in 610 patients with movement disorders.